Status:
COMPLETED
Treatment of Acute and Chronic Ligament and Tendon Injuries With Platelet Rich Plasma
Lead Sponsor:
Stanford University
Collaborating Sponsors:
NYU Langone Health
Conditions:
Tendinopathy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Platelet rich plasma has been used in previous studies to stimulate faster healing of torn ligaments and tendons in order to help reduce pain and restore normal function. This study aims to prove that...
Detailed Description
Pre-procedure diagnosis: The appropriate clinical evaluation will be dictated by the examining physician. Minimal pre-procedure studies will include plain radiographs and MRI. All patients will comple...
Eligibility Criteria
Inclusion
- Acute or chronic ligament or tendon injuries
Exclusion
- Pregnant women,
- children,
- other injuries that require surgical intervention,
- associated fractures,
- systemic disease resulting in an immunocompromised state affecting ability to heal soft tissues
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01406821
Start Date
August 1 2009
End Date
March 15 2019
Last Update
March 29 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305
2
New York University Langone Orthopedic Hospital
New York, New York, United States, 10003